Disruption of the Sarcoglycan–Sarcospan Complex in Vascular Smooth Muscle A Novel Mechanism for Cardiomyopathy and Muscular Dystrophy
暂无分享,去创建一个
K. Campbell | R. Weiss | R. Cohn | Joseph A. Hill | R. Coral-Vázquez | V. Straub | R. Williamson | S. Moore | R. Barresi | R. Davisson | Ron F. Hrstka | R. Hrstka | Dimple Bansal
[1] J. Sanes,et al. ε-Sarcoglycan Replaces α-Sarcoglycan in Smooth Muscle to Form a Unique Dystrophin-Glycoprotein Complex* , 1999, The Journal of Biological Chemistry.
[2] J. Sanes,et al. Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex , 1999, The Journal of cell biology.
[3] E. Hoffman,et al. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations , 1999, Muscle & nerve.
[4] A. Sakamoto,et al. Delineation of genomic deletion in cardiomyopathic hamster , 1999, FEBS letters.
[5] F. Muntoni,et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.
[6] M. Martone,et al. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.
[7] M. Passos-Bueno,et al. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. , 1998, Journal of medical genetics.
[8] K. Campbell,et al. The sarcoglycan complex in limb-girdle muscular dystrophy. , 1998, Current opinion in neurology.
[9] John A. Faulkner,et al. Progressive Muscular Dystrophy in α-Sarcoglycan–deficient Mice , 1998, The Journal of cell biology.
[10] R. Wollmann,et al. γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin , 1998, The Journal of cell biology.
[11] J. Towbin,et al. The role of cytoskeletal proteins in cardiomyopathies. , 1998, Current opinion in cell biology.
[12] K. Campbell,et al. Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex* , 1997, The Journal of Biological Chemistry.
[13] J. Fewell,et al. A treadmill exercise regimen for identifying cardiovascular phenotypes in transgenic mice. , 1997, The American journal of physiology.
[14] K. Campbell,et al. Muscular dystrophies and the dystrophin-glycoprotein complex. , 1997, Current opinion in neurology.
[15] Minoru Hongo,et al. MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.
[16] M. Passos-Bueno,et al. Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene , 1996, Nature Genetics.
[17] Y. Capetanaki,et al. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin , 1996, The Journal of cell biology.
[18] L. Kunkel,et al. Mutations in the Dystrophin-Associated Protein γ-Sarcoglycan in Chromosome 13 Muscular Dystrophy , 1995, Science.
[19] J. Beckmann,et al. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy , 1994, Cell.
[20] J. Ervasti,et al. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin , 1993, The Journal of cell biology.
[21] H. Sweeney,et al. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[22] E. Sonnenblick,et al. Microvascular Spasm in the Cardiomyopathic Syrian Hamster: A Preventable Cause of Focal Myocardial Necrosis , 1982, Circulation.
[23] G. Pöch,et al. Molecular Mechanism of Action of Nicorandil , 1992, Journal of cardiovascular pharmacology.